<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 08/14/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 08/14/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Roger Clema</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">December 13, 1950 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Declined to Specify</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Declined to Specify</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>1119 WESTCHESTER DR E<br/>WEST PALM BEACH, FL 33417-5714, US<br/><br/>Primary Home Phone:  561-688-9402<br/>Mobile Phone:  561-662-6517<br/>Email:  Marieclema@yahoo.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">283997 2.16.840.1.113883.4.391.327187<br/>283997 2.16.840.1.113883.4.391.327187.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">967043d4-7463-46e5-bd8f-7ad33615df00 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">September 7, 2024, 11:44:14 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">David Liporace</td></tr><tr><td class="td_header_role_value internal_format">971 VILLAGE BLVD<br/>WEST PALM BEACH, FL 33409-1944, US<br/><br/>Tel:  561-688-5030<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Yesenia Medina</td></tr><tr><td class="td_header_role_value internal_format">971 VILLAGE BLVD<br/>WEST PALM BEACH, FL 33409-1944, US<br/><br/>Tel:  561-688-5030<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">20956350 2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From August 14, 2024, 15:00:00   to August 14, 2024, 15:40:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Yesenia Medina</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">971 VILLAGE BLVD<br/>WEST PALM BEACH, FL 33409-1944, US<br/><br/>Tel:  561-688-5030<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">MARIE CLEMA<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1119 WESTCHESTER DR E<br/>WEST PALM BEACH, FL 33417-5714, US<br/><br/>Tel:  561-688-9402<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Roger Clema<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  561-688-9402<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Yesenia Medina signed at August 14, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">971 VILLAGE BLVD<br/>WEST PALM BEACH, FL 33409-1944, US<br/><br/>Tel:  561-688-5030<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">MyCare Medical Group</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1785 NORTHPOINTE PKWY<br/>STE 300<br/>LUTZ, FL 33558-5742, US<br/><br/>Tel:  813-536-7277<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Problems</a></li><li><a href="#id7">Vital Signs</a></li><li><a href="#id8">Encounters</a></li><li><a href="#id9">Assessments</a></li><li><a href="#id10">Plan Of Treatment</a></li><li><a href="#id11">Progress Notes</a></li><li><a href="#id12">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">EXTRA LAVENDER-TOP TUBE</span><br/>Reviewed date:08/16/2024 08:41:22 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING</td></tr><tr><td colspan="4"><span class="content_span">PSA (FREE AND TOTAL) (31348)</span><br/>Reviewed date:08/16/2024 08:41:22 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING</td></tr><tr><td ID="result2_attr1">PSA, TOTAL</td><td>8.4</td><td>&lt; OR = 4.0 ng/mL</td><td/></tr><tr><td ID="result2_attr2">PSA, FREE</td><td>3.2</td><td/><td/></tr><tr><td ID="result2_attr3">PSA, % FREE</td><td>38</td><td>&gt;25 % (calc)</td><td ID="result2_attr3_notes"><p/><p>PSA(ng/mL)      Free PSA(%)     Estimated(x) Probability</p><p>                                     of Cancer(as%)</p><p>0-2.5              (*)               Approx. 1</p><p>2.6-4.0(1)         0-27(2)                   24(3)</p><p>4.1-10(4)          0-10                      56</p><p>                   11-15                     28</p><p>                   16-20                     20</p><p>                   21-25                     16</p><p>                   &gt;or =26                   8</p><p>&gt;10(+)             N/A                      &gt;50</p><p>References:(1)Catalona et al.:Urology 60: 469-474 (2002)</p><p>           (2)Catalona et al.:J.Urol 168: 922-925 (2002)</p><p>              Free PSA(%)   Sensitivity(%)  Specificity(%)</p><p>              &lt; or = 25          85              19</p><p>              &lt; or = 30          93               9</p><p>           (3)Catalona et al.:JAMA 277: 1452-1455 (1997)</p><p>           (4)Catalona et al.:JAMA 279: 1542-1547 (1998)</p><p>(x)These estimates vary with age, ethnicity, family</p><p>   history and DRE results.</p><p>(*)The diagnostic usefulness of % Free PSA has not been</p><p>   established in patients with total PSA below 2.6 ng/mL</p><p>(+)In men with PSA above 10 ng/mL, prostate cancer risk is</p><p>   determined by total PSA alone.</p><p>The Total PSA value from this assay system is</p><p>standardized against the equimolar PSA standard.</p><p>The test result will be approximately 20% higher</p><p>when compared to the WHO-standardized Total PSA</p><p>(Siemens assay). Comparison of serial PSA results</p><p>should be interpreted with this fact in mind.</p><p>PSA was performed using the Beckman Coulter</p><p>Immunoassay method. Values obtained from different</p><p>assay methods cannot be used interchangeably. PSA</p><p>levels, regardless of value, should not be interpreted</p><p>as absolute evidence of the presence or absence of</p><p>disease.</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>6 month f/u</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Latanoprost 0.005 %</td><td ID="instruction1"> Ophthalmic for 55 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Tamsulosin HCl 0.4 MG</td><td ID="instruction2">2 capsules Oral Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Timolol Maleate 0.5 %</td><td ID="instruction3">INSTILL ONE DROP INTO EACH EYE TWICE DAILY Ophthalmic for Not Available</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">metFORMIN HCl 1000 MG</td><td ID="instruction4">1 tablet with a meal Oral BID for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">amLODIPine Besy-Benazepril HCl 5-10 MG</td><td ID="instruction5">1 capsule Orally once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Finasteride 5 MG</td><td ID="instruction6">1 tablet Orally Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Accu-Chek Aviva Plus w/Device</td><td ID="instruction7">as directed 3 times a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table><span class="content_span">Household</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Marital status:</td><td>married</td><td/></tr><tr><td>Number of adults in household:</td><td>6</td><td/></tr><tr><td>Number of children in household:</td><td>0</td><td/></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>nonsmoker</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>399068003</td><td ID="Problem1">PC (prostate cancer) (C61)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>33286000</td><td ID="Problem2">Immunodeficiency due to conditions classified elsewhere (D84.81)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Neutropenia (165517008)</td><td ID="Problem3">Neutropenia, unspecified (D70.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Blood pressure systolic</th><td>122 mm Hg</td><td>08/14/2024</td></tr><tr><th ID="vital2">Blood pressure diastolic</th><td>80 mm Hg</td><td>08/14/2024</td></tr><tr><th ID="vital3">Heart Rate</th><td>75 /min</td><td>08/14/2024</td></tr><tr><th ID="vital4">Height</th><td>66.00 in</td><td>08/14/2024</td></tr><tr><th ID="vital5">Weight</th><td>220 lbs</td><td>08/14/2024</td></tr><tr><th ID="vital6">BMI</th><td>35.51 kg/m2</td><td>08/14/2024</td></tr><tr><th ID="vital7">Oximetry</th><td>99 %</td><td>08/14/2024</td></tr><tr><th ID="vital8">Height-cm</th><td>167.64 cm</td><td>08/14/2024</td></tr><tr><th ID="vital9">Weight-kg</th><td>99.79 kg</td><td>08/14/2024</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM WPB 971 Village Blvd</td><td>971 VILLAGE BLVD WEST PALM BEACH, FL 33409-1944</td><td>08/14/2024</td><td>Yesenia Medina</td><td>Benign prostatic hyperplasia with lower urinary tract symptoms N40.1 ; Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin E11.69 ; PC (prostate cancer) C61 ; Primary open angle glaucoma (POAG) of right eye, mild stage H40.1111 ; Immunodeficiency due to conditions classified elsewhere D84.81 and Neutropenia, unspecified D70.9</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">08/14/2024</td><td>Benign prostatic hyperplasia with lower urinary tract symptoms (ICD-10 - N40.1)</td><td/><td>recheck PSA- increasing- increase Tamsulosin to 0.8 mg daily and cont Finasteride 5mg daily per pt no missed doses</td><td/></tr><tr><td ID="ref2">08/14/2024</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (ICD-10 - E11.69)</td><td>+HLP</td><td>controlled, cont ADA portion control and active lifestyle- no need for BS monitoring at home</td><td/></tr><tr><td ID="ref3">08/14/2024</td><td>PC (prostate cancer) (ICD-10 - C61)</td><td/><td><p>request MRI and f/u with uro as scheduled- surveillance biopsy pending to be scheduled - biopsy last year per pt</p><p>request pathology recrods- MRI PiRads 2 5/2024</p></td><td/></tr><tr><td ID="ref4">08/14/2024</td><td>Primary open angle glaucoma (POAG) of right eye, mild stage (ICD-10 - H40.1111)</td><td/><td>assured a1c DM good control and copy to pt to take to upcoming optho appt</td><td/></tr><tr><td ID="ref5">08/14/2024</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td/><td>prostate cancer observe for potential s/sxs of infections</td><td/></tr><tr><td ID="ref6">08/14/2024</td><td>Neutropenia, unspecified (ICD-10 - D70.9)</td><td/><td>decreasing count from last year to 1/2024- recheck and observe</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Tamsulosin HCl 0.4 MG</td><td>2 capsules Oral Once a day for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Finasteride 5 MG</td><td>1 tablet Orally Once a day for 30 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Benign prostatic hyperplasia with lower urinary tract symptoms</td><td>recheck PSA- increasing- increase Tamsulosin to 0.8 mg daily and cont Finasteride 5mg daily per pt no missed doses</td></tr><tr><td ID="instructionpot2">Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</td><td>controlled, cont ADA portion control and active lifestyle- no need for BS monitoring at home</td></tr><tr><td ID="instructionpot3">PC (prostate cancer)</td><td><p>request MRI and f/u with uro as scheduled- surveillance biopsy pending to be scheduled - biopsy last year per pt</p><p>request pathology recrods- MRI PiRads 2 5/2024</p></td></tr><tr><td ID="instructionpot4">Primary open angle glaucoma (POAG) of right eye, mild stage</td><td>assured a1c DM good control and copy to pt to take to upcoming optho appt</td></tr><tr><td ID="instructionpot5">Immunodeficiency due to conditions classified elsewhere</td><td>prostate cancer observe for potential s/sxs of infections</td></tr><tr><td ID="instructionpot6">Neutropenia, unspecified</td><td>decreasing count from last year to 1/2024- recheck and observe</td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">VENIPUNCT, ROUTINE*</td><td>08/14/2024</td></tr><tr><td ID="futureTest2">PSA FREE AND TOTAL</td><td>08/14/2024</td></tr><tr><td ID="futureTest3">CBC (INCLUDES DIFF/PLT) (6399)</td><td>08/29/2024</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 6 Weeks, Reason: lab and MRI results</td></tr><tr><td ID="futureAppt1">Provider Name:Yesenia Medina, 09/25/2024 08:40:00 AM, 971 VILLAGE BLVD, WEST PALM BEACH, FL, 33409-1944, 561-688-5030</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>CLEMA, Roger <span class="bold">DOB:</span> 12/13/1950 (73 yo M) <span class="bold">Acc No.</span> 283997 <span class="bold">DOS:</span> 08/14/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>CLEMA, Roger<br/><span class="bold">Account Number: </span>283997</td><td align="right"><span class="bold">Provider: </span>Yesenia Medina, DO</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>12/13/1950<span class="bold">   Age: </span>73 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>08/14/2024</td></tr><tr><td><span class="bold">Phone: </span>561-688-9402</td></tr><tr><td colspan="2"><span class="bold">Address: </span>1119 WESTCHESTER DR E, WEST PALM BEACH, FL-33417-5714</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>David Liporace</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   6 month f/u</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">AWV-COA-HEDIS</span>: <br/>      Screening: <br/>         Colon Cancer Screening Date: <span class="italics"> Due</span><br/>         PSA: <span class="italics">Up to date 12.3 - 04/25/2024</span><br/>         Cardiovascular Disease Screening (Lipid Panel): <span class="italics"> 2024</span><br/>      Immunizations: <br/>         Influenza: <span class="italics"> Pt declines</span><br/>      Diabetes Screening: <br/>         Has patient had a recent A1C <span class="italics">Yes</span><br/>         A1C Result <span class="italics">6.4 04/25/2024</span><br/>         Has patient completed a Microalbumin/Creatinine Ratio Test: <span class="italics">Yes 04/25/2024 nml at 27</span><br/>   <span class="Underline">Diagnostic Imaging</span>: <br/>      EKG 04/19/2024. <br/>   <span class="Underline">Today</span>: <br/>      Patient is here for DM2 per pt no BS monitor at home- a1c 6.4 4/2024 and prior 6.6 and copy of a1c to pt to take to optho monitoring glaucoma and using all medications as directed- per pt has noted some decreased urine stream force and hesitancy w/o dysuria- noted increasing PSA and reviewed uro note 5/2024- request MRI results as per uro. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      Takes medication on time <span class="content_span">admits</span>. Patient denies  fever,  weakness.   <br/>   <span class="Underline">Ophthalmologic</span>: <br/>      Patient denies blurry vision,  discharge,  red eye(s).   <br/>   <span class="Underline">Respiratory</span>: <br/>      Patient denies chronic cough,  shortness of breath,  sputum production.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Patient denies chest pain,  chest pain with exertion,  irregular heartbeat.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Patient denies abdominal pain,  diarrhea,  rectal bleeding, vomiting.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Patient denies abdominal pain / swelling,  blood in the urine,  frequent urination, painful urination.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Patient denies back pain,  joint stiffness,  swollen joints, history of gout.   <br/>   <span class="Underline">Skin</span>: <br/>      Patient denies  changing moles,  skin lesion(s).   <br/>   <span class="Underline">Neurologic</span>: <br/>      Patient denies dizziness,  gait abnormality,  headache.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Patient denies delusions,  depressed mood,  difficulty sleeping.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> Colonoscopy -2020-Polyps </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> No Hospitalization History.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> No Family History documented.. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking <br/>         Tobacco use: <span class="italics">nonsmoker</span><br/>   <span class="Underline">Household:</span> <br/>       Household <br/>         Marital status: <span class="italics">married</span><br/>         Number of adults in household: <span class="italics">6</span><br/>         Number of children in household: <span class="italics">0</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingAccu-Chek Aviva Plus w/Device Kit as directed 3 times a day  amLODIPine Besy-Benazepril HCl 5-10 MG Capsule 1 capsule Orally once a day Finasteride 5 MG Tablet 1 tablet Orally Once a day Latanoprost 0.005 % Solution  Ophthalmic  metFORMIN HCl 1000 MG Tablet 1 tablet with a meal Oral BID Tamsulosin HCl 0.4 MG Capsule 1 capsule Oral Once a day Timolol Maleate 0.5 % Solution INSTILL ONE DROP INTO EACH EYE TWICE DAILY Ophthalmic  Taking Accu-Chek Aviva Plus w/Device Kit as directed 3 times a day  Taking amLODIPine Besy-Benazepril HCl 5-10 MG Capsule 1 capsule Orally once a day Taking Finasteride 5 MG Tablet 1 tablet Orally Once a day Taking Latanoprost 0.005 % Solution  Ophthalmic  Taking metFORMIN HCl 1000 MG Tablet 1 tablet with a meal Oral BID Taking Tamsulosin HCl 0.4 MG Capsule 1 capsule Oral Once a day Taking Timolol Maleate 0.5 % Solution INSTILL ONE DROP INTO EACH EYE TWICE DAILY Ophthalmic  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 66.00 in, Wt: <span class="bold">220</span> lbs, Wt-kg: 99.79 kg, BMI: <span class="bold">35.51</span> Index, BP: <span class="bold">122/80</span> mm Hg, HR: <span class="bold">75</span> /min, Oxygen sat %: <span class="bold">99</span> %, Body Surface Area: 2.15, Ht-cm: 167.64 cm.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:PSA (FREE AND TOTAL) (31348)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">04/24/2024</td><td align="left">08/08/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">08:47 AM</td><td align="left">02:34 PM</td></tr><tr><td align="left">Order Date</td><td align="left">04/24/2024</td><td align="left">08/08/2023</td></tr><tr><td align="left">PSA, FREE</td><td align="left">2.8<br/>(Ref Range: ng/mL)</td><td align="left">3.4<br/>(Ref Range: ng/mL)</td></tr><tr><td align="left">PSA, TOTAL</td><td class="bold" align="left">12.3    H<br/>(Ref Range: &lt; OR = 4.0 ng/mL)</td><td class="bold" align="left">8.4    H<br/>(Ref Range: &lt; OR = 4.0 ng/mL)</td></tr><tr><td align="left">PSA, % FREE</td><td align="left">NOT CALCULATED<br/>(Ref Range: &gt;25 % (calc))</td><td align="left">40<br/>(Ref Range: &gt;25 % (calc))</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:HEMOGLOBIN A1c (496)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">04/24/2024</td><td align="left">01/25/2024</td><td align="left">08/08/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">08:47 AM</td><td align="left">08:42 AM</td><td align="left">02:34 PM</td></tr><tr><td align="left">Order Date</td><td align="left">04/24/2024</td><td align="left">01/25/2024</td><td align="left">08/08/2023</td></tr><tr><td align="left">HEMOGLOBIN A1c</td><td class="bold" align="left">6.4    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td><td class="bold" align="left">6.6    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td><td class="bold" align="left">6.4    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">04/24/2024</td><td align="left">01/25/2024</td></tr><tr><td align="left">Collection Time</td><td align="left">08:47 AM</td><td align="left">08:42 AM</td></tr><tr><td align="left">Order Date</td><td align="left">04/24/2024</td><td align="left">01/25/2024</td></tr><tr><td align="left">COLOR</td><td align="left">YELLOW<br/>(Ref Range: YELLOW)</td><td align="left">YELLOW<br/>(Ref Range: YELLOW)</td></tr><tr><td align="left">APPEARANCE</td><td align="left">CLEAR<br/>(Ref Range: CLEAR)</td><td align="left">CLEAR<br/>(Ref Range: CLEAR)</td></tr><tr><td align="left">BILIRUBIN</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">KETONES</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">SPECIFIC GRAVITY</td><td align="left">1.012<br/>(Ref Range: 1.001-1.035)</td><td align="left">1.011<br/>(Ref Range: 1.001-1.035)</td></tr><tr><td align="left">OCCULT BLOOD</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">PH</td><td align="left">7.5<br/>(Ref Range: 5.0-8.0)</td><td align="left">6.5<br/>(Ref Range: 5.0-8.0)</td></tr><tr><td align="left">PROTEIN</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">NITRITE</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">LEUKOCYTE ESTERASE</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">WBC</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td></tr><tr><td align="left">RBC</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 2 /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 2 /HPF)</td></tr><tr><td align="left">SQUAMOUS EPITHELIAL CELLS</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td></tr><tr><td align="left">BACTERIA</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /HPF)</td></tr><tr><td align="left">HYALINE CAST</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /LPF)</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /LPF)</td></tr><tr><td align="left">GLUCOSE</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:COMPREHENSIVE METABOLIC PANEL (10231)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">04/24/2024</td><td align="left">01/25/2024</td><td align="left">08/08/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">08:47 AM</td><td align="left">08:42 AM</td><td align="left">02:34 PM</td></tr><tr><td align="left">Order Date</td><td align="left">04/24/2024</td><td align="left">01/25/2024</td><td align="left">08/08/2023</td></tr><tr><td align="left">GLUCOSE</td><td class="bold" align="left">118    H<br/>(Ref Range: 65-99 mg/dL)</td><td class="bold" align="left">121    H<br/>(Ref Range: 65-99 mg/dL)</td><td align="left">97<br/>(Ref Range: 65-99 mg/dL)</td></tr><tr><td align="left">UREA NITROGEN (BUN)</td><td align="left">10<br/>(Ref Range: 7-25 mg/dL)</td><td align="left">10<br/>(Ref Range: 7-25 mg/dL)</td><td align="left">9<br/>(Ref Range: 7-25 mg/dL)</td></tr><tr><td align="left">CREATININE</td><td align="left">0.89<br/>(Ref Range: 0.70-1.28 mg/dL)</td><td align="left">0.86<br/>(Ref Range: 0.70-1.28 mg/dL)</td><td align="left">0.91<br/>(Ref Range: 0.70-1.28 mg/dL)</td></tr><tr><td align="left">BUN/CREATININE RATIO</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td></tr><tr><td align="left">SODIUM</td><td align="left">139<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">138<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">141<br/>(Ref Range: 135-146 mmol/L)</td></tr><tr><td align="left">POTASSIUM</td><td align="left">5.2<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.5<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.5<br/>(Ref Range: 3.5-5.3 mmol/L)</td></tr><tr><td align="left">CHLORIDE</td><td align="left">106<br/>(Ref Range: 98-110 mmol/L)</td><td align="left">105<br/>(Ref Range: 98-110 mmol/L)</td><td align="left">106<br/>(Ref Range: 98-110 mmol/L)</td></tr><tr><td align="left">CARBON DIOXIDE</td><td align="left">25<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">26<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">23<br/>(Ref Range: 20-32 mmol/L)</td></tr><tr><td align="left">CALCIUM</td><td align="left">9.4<br/>(Ref Range: 8.6-10.3 mg/dL)</td><td align="left">9.5<br/>(Ref Range: 8.6-10.3 mg/dL)</td><td align="left">9.5<br/>(Ref Range: 8.6-10.3 mg/dL)</td></tr><tr><td align="left">PROTEIN, TOTAL</td><td align="left">7.2<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">7.3<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">7.5<br/>(Ref Range: 6.1-8.1 g/dL)</td></tr><tr><td align="left">ALBUMIN</td><td align="left">4.5<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">4.5<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">4.6<br/>(Ref Range: 3.6-5.1 g/dL)</td></tr><tr><td align="left">GLOBULIN</td><td align="left">2.7<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.8<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.9<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td></tr><tr><td align="left">ALBUMIN/GLOBULIN RATIO</td><td align="left">1.7<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.6<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.6<br/>(Ref Range: 1.0-2.5 (calc))</td></tr><tr><td align="left">BILIRUBIN, TOTAL</td><td align="left">0.9<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">1.1<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">0.9<br/>(Ref Range: 0.2-1.2 mg/dL)</td></tr><tr><td align="left">ALKALINE PHOSPHATASE</td><td align="left">66<br/>(Ref Range: 35-144 U/L)</td><td align="left">67<br/>(Ref Range: 35-144 U/L)</td><td align="left">66<br/>(Ref Range: 35-144 U/L)</td></tr><tr><td align="left">AST</td><td align="left">12<br/>(Ref Range: 10-35 U/L)</td><td align="left">14<br/>(Ref Range: 10-35 U/L)</td><td align="left">17<br/>(Ref Range: 10-35 U/L)</td></tr><tr><td align="left">ALT</td><td align="left">11<br/>(Ref Range: 9-46 U/L)</td><td align="left">16<br/>(Ref Range: 9-46 U/L)</td><td align="left">17<br/>(Ref Range: 9-46 U/L)</td></tr><tr><td align="left">EGFR</td><td align="left">90<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">91<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">90<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:ALBUMIN, RANDOM URINE W/CREATININE (6517)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">04/24/2024</td><td align="left">01/25/2024</td><td align="left">08/08/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">08:47 AM</td><td align="left">08:42 AM</td><td align="left">02:34 PM</td></tr><tr><td align="left">Order Date</td><td align="left">04/24/2024</td><td align="left">01/25/2024</td><td align="left">08/08/2023</td></tr><tr><td align="left">CREATININE, RANDOM URINE</td><td align="left">82<br/>(Ref Range: 20-320 mg/dL)</td><td align="left">68<br/>(Ref Range: 20-320 mg/dL)</td><td align="left">68<br/>(Ref Range: 20-320 mg/dL)</td></tr><tr><td align="left">ALBUMIN, URINE</td><td align="left">2.2<br/>(Ref Range: See Note: mg/dL)</td><td align="left">2.4<br/>(Ref Range: See Note: mg/dL)</td><td align="left">1.9<br/>(Ref Range: See Note: mg/dL)</td></tr><tr><td align="left">ALBUMIN/CREATININE RATIO, RANDOM URINE</td><td align="left">27<br/>(Ref Range: &lt;30 mg/g creat)</td><td class="bold" align="left">35    H<br/>(Ref Range: &lt;30 mcg/mg creat)</td><td align="left">28<br/>(Ref Range: &lt;30 mcg/mg creat)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, well-nourished and in no acute distress. <br/>      HEENT  eyes clear, nares clear, gross hearing intact. <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Abdomen: soft with good bowel sounds, nontender. <br/>      Extremities no edema. <br/>      Back: full range of motion without difficulty,  no costovertebral angle tenderness. <br/>      Skin: skin is warm and dry, with no rashes. <br/>      Breasts: not examined. <br/>      Eyes: pupils equal, round, reactive to light and accommodation. <br/>      Rectal: with normal tone, soft brown stool, no masses and no blood or melena<br/><br/>no masses. <br/>      Psych: normal affect / mood.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Benign prostatic hyperplasia with lower urinary tract symptoms - N40.1 (Primary)   2. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin - E11.69   <content><span class="bold">Notes : </span>+HLP</content>   3. PC (prostate cancer) - C61   4. Primary open angle glaucoma (POAG) of right eye, mild stage - H40.1111   5. Immunodeficiency due to conditions classified elsewhere - D84.81   6. Neutropenia, unspecified - D70.9   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Benign prostatic hyperplasia with lower urinary tract symptoms</span> <br/>Refill Finasteride Tablet, 5 MG, 1 tablet, Orally, Once a day, 30 days, 30 Tablet, Refills 3; Refill Tamsulosin HCl Capsule, 0.4 MG, 2 capsules, Oral, Once a day, 30 days, 60 Capsule, Refills 3.  <br/>     <span class="Underline">LAB: PSA (FREE AND TOTAL) (31348) (Collection Date &amp; Time - 08/14/2024 03:14 PM)</span><br/>     <span class="Underline">Procedure: VENIPUNCT, ROUTINE* (Ordered for 08/14/2024)</span><br/>Notes: recheck PSA- increasing- increase Tamsulosin to 0.8 mg daily and cont Finasteride 5mg daily per pt no missed doses  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</span> <br/>Notes: controlled, cont ADA portion control and active lifestyle- no need for BS monitoring at home  </td></tr><tr><td/></tr><tr><td><span class="bold">3. PC (prostate cancer)</span> <br/>     <span class="Underline">LAB: PSA FREE AND TOTAL (Ordered for 08/14/2024)</span><br/>Notes: request MRI and f/u with uro as scheduled- surveillance biopsy pending to be scheduled - biopsy last year per pt<br/><br/><br/>request pathology recrods- MRI PiRads 2 5/2024  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Primary open angle glaucoma (POAG) of right eye, mild stage</span> <br/>Notes: assured a1c DM good control and copy to pt to take to upcoming optho appt  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Immunodeficiency due to conditions classified elsewhere</span> <br/>Notes: prostate cancer observe for potential s/sxs of infections  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Neutropenia, unspecified</span> <br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399) (Ordered for 08/29/2024)</span><br/>Notes: decreasing count from last year to 1/2024- recheck and observe  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP3079F DIAST BP 80-89 MM HG3075F SYST BP GE 130 - 139MM HG</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 6 Weeks (Reason: lab and MRI results)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP. <br/>3079F DIAST BP 80-89 MM HG. <br/>3075F SYST BP GE 130 - 139MM HG. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by Yesenia Medina , DO, OS10520  on 08/15/2024 at 01:11 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Yesenia Medina, DO</td><td align="right"><span class="bold">Date: </span>08/14/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 09/07/2024 11:44 AM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id12" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="7">AWV-COA-HEDIS</td><td rowspan="3">Screening:</td><td>Colon Cancer Screening Date:: </td><td>Due</td></tr><tr><td>PSA:: Up to date</td><td>12.3 - 04/25/2024</td></tr><tr><td>Cardiovascular Disease Screening (Lipid Panel):: </td><td>2024</td></tr><tr><td>Immunizations:</td><td>Influenza:: </td><td>Pt declines</td></tr><tr><td rowspan="3">Diabetes Screening:</td><td>Has patient had a recent A1C: Yes</td><td/></tr><tr><td> ∟A1C Result: 6.4</td><td>04/25/2024</td></tr><tr><td>Has patient completed a Microalbumin/Creatinine Ratio Test:: Yes</td><td>04/25/2024 nml at 27</td></tr><tr><td>Today</td><td>Patient is here for</td><td colspan="2">DM2 per pt no BS monitor at home- a1c 6.4 4/2024 and prior 6.6 and copy of a1c to pt to take to optho monitoring glaucoma and using all medications as directed- per pt has noted some decreased urine stream force and hesitancy w/o dysuria- noted increasing PSA and reviewed uro note 5/2024- request MRI results as per uro</td></tr><tr><td>Diagnostic Imaging</td><td>EKG</td><td colspan="2">04/19/2024</td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="12">General Examination</td><td>General appearance:</td><td colspan="2">alert, well-nourished and in no acute distress</td></tr><tr><td>Eyes:</td><td colspan="2">pupils equal, round, reactive to light and accommodation</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Abdomen:</td><td colspan="2">soft with good bowel sounds, nontender</td></tr><tr><td>Skin:</td><td colspan="2">skin is warm and dry, with no rashes</td></tr><tr><td>Back:</td><td colspan="2">full range of motion without difficulty, no costovertebral angle tenderness</td></tr><tr><td>Breasts:</td><td colspan="2">not examined</td></tr><tr><td>Rectal:</td><td colspan="2">with normal tone, soft brown stool, no masses and no blood or melena  no masses</td></tr><tr><td>Psych:</td><td colspan="2">normal affect / mood</td></tr><tr><td>HEENT</td><td colspan="2">eyes clear, nares clear, gross hearing intact</td></tr><tr><td>Extremities</td><td colspan="2">no edema</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>